How Close Are We to Personalized Treatment for Diabetes? (0:26)
Many experts are interested in developing personalized diabetes treatment plans based on genetic information. In this video, HealthMaker Daniel Kelly, MD, talks about when patients can expect this to happen.
Read Transcript
I think we could begin to use metabolites and genetic information in five to ten years, five years let's say. But to get this entire panel validated requires longitudinal studies. So that will take a decade and beyond but we could start influencing and making our approach more precise, within the next five years, I would say.
Daniel Kelly, MD, is senior vice president, Tavistock Distinguished Professor and scientific director of the Sanford-Burnham Medical Research Institute at Lake Nona. He specializes in heart disease, metabolic Syndrome, obesity and diabetes.
